Literature DB >> 9423715

Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors.

A C Stanley1, H Y Park, T J Phillips, V Russakovsky, J O Menzoian.   

Abstract

PURPOSE: Although the slow healing rate of venous ulcers is well known, the underlying defect in the healing process is not well understood. The purpose of this study was to examine the cellular characteristics of fibroblasts taken from venous ulcers (wound-fb) and compare them with the fibroblasts of normal tissue (normal-fb).
METHODS: Biopsy specimens were obtained from wound margins and normal tissue of the upper thigh in each patient. Dermal fibroblasts were isolated from explant cultures in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. These cells were then plated at 1000 cells per plate, and total cells per plate were counted over time so that growth curves could be generated. In further experimentation, media was supplemented with additional calf serum (20%, 30%, 40%, 50%) and growth factors (epidermal growth factor, basic fibroblast growth factor, interleukin-1 beta) in an attempt to stimulate growth.
RESULTS: Two major differences were noted: (1) normal-fb replicated more rapidly than wound-fb; and (2) the morphologic features of wound-fb were different. Normal-fb were compact and tapered, with well-defined nuclear morphologic features. Wound-fb were larger and polygonal in shape, with less-uniform nuclear morphologic features. Additional calf serum in tissue culture media enhanced normal-fb growth but had no effect on wound-fb. Supplementation of media with growth factors stimulated the growth of wound-fb. Statistically significant differences were noted at day 10 and 14 with basic fibroblast growth factor supplementation (p = 0.02 and 0.0001, respectively) and at day 14 with epidermal growth factor (p = 0.008). Although interleukin-1 beta stimulated cell growth in five of six patients, the differences observed were not statistically significant.
CONCLUSIONS: Our data demonstrate that wound-fb proliferate at a slower rate and are morphologically distinct from normal-fb. These characteristics are typical of aged or senescent cells. This decreased growth can be stimulated by growth factors basic fibroblast growth factor, epidermal growth factor, and interleukin-1 beta. Slowed growth may be partially responsible for the defect in healing of venous stasis ulcers. Furthermore, we believe that in some patients ulcer healing may be improved by exogenous provision of specific growth factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9423715     DOI: 10.1016/s0741-5214(97)70012-0

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  20 in total

Review 1.  Science, medicine and the future: healing chronic wounds.

Authors:  K G Harding; H L Morris; G K Patel
Journal:  BMJ       Date:  2002-01-19

Review 2.  Mesenchymal stem cells: potential for therapy and treatment of chronic non-healing skin wounds.

Authors:  Giovanni Marfia; Stefania Elena Navone; Clara Di Vito; Nicola Ughi; Silvia Tabano; Monica Miozzo; Carlo Tremolada; Gianni Bolla; Chiara Crotti; Francesca Ingegnoli; Paolo Rampini; Laura Riboni; Roberta Gualtierotti; Rolando Campanella
Journal:  Organogenesis       Date:  2015       Impact factor: 2.500

3.  Acceleration of diabetic wound healing by a cryopreserved living dermal substitute created by micronized amnion seeded with fibroblasts.

Authors:  Yongjun Zheng; Shizhao Ji; Haibin Wu; Song Tian; Xingtong Wang; Pengfei Luo; He Fang; Zhihong Wang; Junjie Wang; Zhongshan Wang; Shichu Xiao; Zhaofan Xia
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

Review 4.  Wound bed preparation and a brief history of TIME.

Authors:  Gregory S Schultz; David J Barillo; David W Mozingo; Gloria A Chin
Journal:  Int Wound J       Date:  2004-04       Impact factor: 3.315

5.  Regulation of matrix contraction in chronic venous disease.

Authors:  P J Pappas; B K Lal; N Ohara; S Saito; L Zapiach; W N Durán
Journal:  Eur J Vasc Endovasc Surg       Date:  2009-06-27       Impact factor: 7.069

6.  Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?

Authors:  Christopher G Elliott; Douglas W Hamilton
Journal:  J Cell Commun Signal       Date:  2011-04-19       Impact factor: 5.782

7.  Soft tissue fibroblasts from well healing and chronic human wounds show different rates of myofibroblasts in vitro.

Authors:  Florian Schwarz; Martina Jennewein; Monika Bubel; Joerg H Holstein; Tim Pohlemann; Martin Oberringer
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

8.  Treatment of intractable skin ulcers caused by vascular insufficiency with allogeneic cultured dermal substitute: a report of eight cases.

Authors:  Tomonori Taniguchi; Yasuyuki Amoh; Kenichi Tanabe; Kensei Katsuoka; Yoshimitsu Kuroyanagi
Journal:  J Artif Organs       Date:  2011-08-23       Impact factor: 1.731

Review 9.  Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment.

Authors:  Jorge Berlanga-Acosta
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

Review 10.  Activity of mesenchymal stem cells in therapies for chronic skin wound healing.

Authors:  Austin Nuschke
Journal:  Organogenesis       Date:  2013-12-10       Impact factor: 2.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.